About The Medical Condition EN1639A
Find the definition of the medical term EN1639A. EN1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN1639A
| EN1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Guanine Nucleotide Exchange Factors ‐ Protein factors that promote the exchange of GTP for GDP bound…
- Rheumatic Chorea ‐ Acquired and hereditary conditions which feature CHOREA as a…
- Transitional Cell Carcinoma ‐ A malignant neoplasm derived from transitional epithelium, occurring…
- Hydroxymethylbilane Synthetase ‐ An enzyme that catalyzes the formation of hydroxymethylbilane…
- Cervical Ripening ‐ A change in the cervix with respect to its readiness to relax.…
- Evaluations ‐ Studies determining the effectiveness or value of processes,…
- Chromaffin Cell ‐ Cells that store epinephrine secretory vesicles. During times…
- Glutathione S-Transferase 3 ‐ A transferase that catalyzes the addition of aliphatic, aromatic,…
- Alveolodental Membranes ‐ Fibrous connective tissue surrounding the root of a tooth that…
- Soft Tissue Sarcomas ‐ A connective tissue neoplasm formed by proliferation of mesodermal…